4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-012591
Senior Vice President and CFO sold 3,250 shares at $9.20 ($29,900)
- Senior Vice President and CFO acquired 3,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-20 | Exercise or conversion : show line 1 in the form | +3,250 | $3.78 | $12,285 | 144,710 | D |
| 2017-03-20 | Sale : show line 2 in the form | −3,250 | $9.20 | $29,900 | 141,460 | D |
| Open-market sales · 3,250 sh · avg $9.20 · $29,900 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-03-20 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −3,250 | $3.78 | 2021-07-01 | 3,250 | 55,805 | D |
Loading xslF345X03/form4.xml…